SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-21
👔
Rani Therapeutics Holdings, Inc.
@RANI_InsiderForm 4 Filing: Imran Talat Buys $25,193 of $RANI
INSIDER PURCHASE
⚡ MATERIALITY: 6/10
corporate issuer
Rani Therapeutics Holdings, Inc.
Ticker: $RANI
Transaction Value
$25,193
Price/Share: $0.72
transaction date
2026-07-17
Shares: 35,000
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Imran Talat, holds the title of Chief Executive Officer at Rani Therapeutics Holdings, Inc..
On 2026-07-17, the insider transacted 35,000 shares.The shares were transacted at a weighted average price of $0.72 per share, resulting in a total market-relevant value of $25,193.
Executive Summary Summary
Imran Talat (Chief Executive Officer) bought $25K of $RANI
Post-Transaction Position: 469,736 shares
SEC Accession No: 0001869579-26-000007 (CIK: 1869579)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.